Supernus Pharmaceuticals | Spese Di Vendita E Di Amministrazione



Selling And Administration Expenses Cambiamento Data
Abbott USD 3.05B 144M 2025-03
ANI Pharmaceuticals USD 69.72M 9.36M 2024-12
Aurora Cannabis CAD 38.18M 2.05M 2024-12
Bristol-Myers Squibb USD 1.58B 521M 2025-03
Canopy Growth CAD 40.62M 308K 2024-12
Corcept Therapeutics USD 83.37M 9.63M 2024-12
Eisai JPY 104.52B 7.1B 2024-12
Eli Lilly USD 2.36B 62.3M 2025-03
Indivior 132M 179M 2025-03
Novo Nordisk 16.59B 501M 2024-09
Pacira USD 79.61M 5.28M 2024-12
Perrigo USD 234.8M 36.7M 2024-12
Pfizer USD 3.01B 1.27B 2025-03
Supernus Pharmaceuticals USD 79.41M 9.66M 2024-12
United Therapeutics USD 170.1M 7.6M 2025-03
Xeris Pharmaceuticals USD 80.28M 35.31M 2024-12



Supernus Pharmaceuticals Spese Di Vendita E Di Amministrazione - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.